Advertisement
Three takes. First, Mizuho, which has been consistently virus bearish over the past year:
Omicron–what we know
“Omicron”, as the WHO has classified it, is reported to have a material number of spike protein mutations. It seems likely at this point that this new variant will have spread much more than has already been identified, due to lack of sequencing in many countries, and for the well-known ability of the SARS-COV-2 virus to spread a symptomatically. Evidence of its spread within South Africa suggests that the Omicron variant has the ability to become dominant over the Beta and Delta strains.
The full text of this article is available to MacroBusiness subscribers
Cancel at any time through our billing provider, Stripe
About the author
David Llewellyn-Smith is Chief Strategist at the MB Fund and MB Super. David is the founding publisher and editor of MacroBusiness and was the founding publisher and global economy editor of The Diplomat, the Asia Pacific's leading geo-politics and economics portal.
He is also a former gold trader and economic commentator at The Sydney Morning Herald, The Age, the ABC and Business Spectator. He is the co-author of The Great Crash of 2008 with Ross Garnaut and was the editor of the second Garnaut Climate Change Review.
Advertisement